Compare ESLT & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESLT | KVUE |
|---|---|---|
| Founded | 1966 | 2022 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Specialty Chemicals |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2B | 32.9B |
| IPO Year | 2002 | 2023 |
| Metric | ESLT | KVUE |
|---|---|---|
| Price | $778.07 | $18.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $667.00 | $19.45 |
| AVG Volume (30 Days) | 76.4K | ★ 18.9M |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | 0.38% | ★ 4.82% |
| EPS Growth | N/A | ★ 40.74 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $15,124,000,000.00 |
| Revenue This Year | $14.29 | $4.85 |
| Revenue Next Year | $8.49 | $2.63 |
| P/E Ratio | ★ $71.88 | $76.16 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $432.85 | $14.02 |
| 52 Week High | $1,016.06 | $22.87 |
| Indicator | ESLT | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 51.50 | 53.42 |
| Support Level | $745.37 | $16.83 |
| Resistance Level | $821.25 | $19.07 |
| Average True Range (ATR) | 18.33 | 0.42 |
| MACD | 2.61 | -0.10 |
| Stochastic Oscillator | 55.03 | 27.10 |
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security and commercial flight capabilities. Its systems and solutions may be installed on new platforms or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company operates in five segments: Aerospace; C4I and Cyber; ISTAR and EW; Land; and ESA. It derives maximum revenue from Land Segment. Geographically, it operates in Israel; North America; Europe; Asia-Pacific; Latin America; and Others.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.